Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Saving of U.S. costs through generic cardiovascular pharmaceuticals 2004-2013

Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars)

by Statista Research Department, last edited Oct 30, 2014
Saving of U.S. costs through generic cardiovascular pharmaceuticals 2004-2013 This statistic displays the cost savings in the United States associated with using generic cardiovascular pharmaceuticals from 2004 to 2013. In 2004, over 18.1 billion U.S. dollars were saved due to generic medication in the cardiovascular therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals.
Show more

Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars)

Cost savings in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Cost savings in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Oct 30, 2014
This statistic displays the cost savings in the United States associated with using generic cardiovascular pharmaceuticals from 2004 to 2013. In 2004, over 18.1 billion U.S. dollars were saved due to generic medication in the cardiovascular therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars"
  • Global overview
The most important statistics
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.